metricas
Clínica e Investigación en Arteriosclerosis PCSK9 inhibitors tug of war: Compliance, adverse events and LDL-cholesterol targ...
Journal Information

Statistics

Follow this link to access the full text of the article

Letter to the Editor
PCSK9 inhibitors tug of war: Compliance, adverse events and LDL-cholesterol target
El tira y afloja de los inhibidores de PCSK9: cumplimiento, efectos adversos y objetivo de colesterol LDL
Francesco Sbrana
Corresponding author
francesco.sbrana@ftgm.it

Corresponding author.
, Beatrice Dal Pino
U.O. Lipoapheresis and Center for Inherited Dyslipidemias, Fondazione Toscana Gabriele Monasterio, Via Moruzzi, 1, 56124 Pisa, Italy
Read
542
Times
was read the article
196
Total PDF
346
Total HTML
Article information
ISSN: 02149168
Original language: English plumx
The statistics are updated each day
Year/Month Html Pdf Total
2026 10 19 11 30
2026 9 53 38 91
2026 8 28 30 58
2026 7 32 18 50
2026 6 17 10 27
2026 5 22 23 45
2026 4 25 14 39
2026 3 34 17 51
2026 2 44 14 58
2026 1 15 9 24
2025 12 13 0 13
2025 10 1 0 1
2025 9 10 0 10
2025 7 1 2 3
2025 5 6 2 8
2025 4 1 0 1
2025 3 25 8 33
Show all

Follow this link to access the full text of the article

asdasdasd